Viewing StudyNCT00103740



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00103740
Status: COMPLETED
Last Update Posted: 2012-06-04
First Post: 2005-02-14

Brief Title: Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Pagets Disease of Bone Including an Extended Observation Period
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Pagets Disease of Bone
Keywords:
Name View
Zoledronic acid risedronate Pagets disease of bone View